These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1178 related articles for article (PubMed ID: 17681162)

  • 21. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
    Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
    Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infliximab therapy downregulation of basic fibroblast growth factor/syndecan 1 link: a possible molecular pathway of mucosal healing in ulcerative colitis.
    Ierardi E; Giorgio F; Zotti M; Rosania R; Principi M; Marangi S; Della Valle N; De Francesco V; Di Leo A; Ingrosso M; Panella C
    J Clin Pathol; 2011 Nov; 64(11):968-72. PubMed ID: 21945924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
    Hafer A; Krämer S; Duncker S; Krüger M; Manns MP; Bischoff SC
    BMC Gastroenterol; 2007 Sep; 7():36. PubMed ID: 17784949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
    Charpentier C; Salleron J; Savoye G; Fumery M; Merle V; Laberenne JE; Vasseur F; Dupas JL; Cortot A; Dauchet L; Peyrin-Biroulet L; Lerebours E; Colombel JF; Gower-Rousseau C
    Gut; 2014 Mar; 63(3):423-32. PubMed ID: 23408350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucosal healing in pediatric Crohn's disease after anti-TNF therapy: a long-term experience at a single center.
    Nobile S; Gionchetti P; Rizzello F; Calabrese C; Campieri M
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):458-65. PubMed ID: 24445727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.
    Ho GT; Chiam P; Drummond H; Loane J; Arnott ID; Satsangi J
    Aliment Pharmacol Ther; 2006 Jul; 24(2):319-30. PubMed ID: 16842459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study.
    Solberg IC; Vatn MH; Høie O; Stray N; Sauar J; Jahnsen J; Moum B; Lygren I;
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1430-8. PubMed ID: 18054751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?
    Flynn A; Kane S
    Curr Opin Gastroenterol; 2011 Jul; 27(4):342-5. PubMed ID: 21378560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paediatric inflammatory bowel disease in New Zealand.
    Yap J; Wesley A; Mouat S; Chin S
    N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. factors influencing mucosal healing in Crohn's disease during infliximab treatment.
    Tursi A; Elisei W; Giorgetti GM; Penna A; Picchio M; Brandimarte G
    Hepatogastroenterology; 2013; 60(125):1041-6. PubMed ID: 23803367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years.
    Hoie O; Wolters FL; Riis L; Bernklev T; Aamodt G; Clofent J; Tsianos E; Beltrami M; Odes S; Munkholm P; Vatn M; Stockbrügger RW; Moum B;
    Gastroenterology; 2007 Feb; 132(2):507-15. PubMed ID: 17258717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
    Laharie D; Filippi J; Roblin X; Nancey S; Chevaux JB; Hébuterne X; Flourié B; Capdepont M; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2013 May; 37(10):998-1004. PubMed ID: 23521659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease--a population-based study.
    Jakobsen C; Bartek J; Wewer V; Vind I; Munkholm P; Groen R; Paerregaard A
    Aliment Pharmacol Ther; 2011 Nov; 34(10):1217-24. PubMed ID: 21981762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
    Bolge SC; Waters H; Piech CT
    Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment Targets in Inflammatory Bowel Disease: Current Status in Daily Practice.
    Römkens TE; Gijsbers K; Kievit W; Hoentjen F; Drenth JP
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):465-471. PubMed ID: 27981302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endomicroscopy for assessing mucosal healing in patients with ulcerative colitis.
    Gheorghe C; Cotruta B; Iacob R; Becheanu G; Dumbrava M; Gheorghe L
    J Gastrointestin Liver Dis; 2011 Dec; 20(4):423-6. PubMed ID: 22187709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.